Vimta Labs Limited

NSE VIMTALABS.NS

Vimta Labs Limited EPS (Diluted) for the year ending March 31, 2024: USD 0.22

Vimta Labs Limited EPS (Diluted) is USD 0.22 for the year ending March 31, 2024, a -15.82% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Vimta Labs Limited EPS (Diluted) for the year ending March 31, 2023 was USD 0.26, a 7.66% change year over year.
Vimta Labs Limited EPS (Diluted) for the year ending March 31, 2022 was USD 0.24, a 82.51% change year over year.
Vimta Labs Limited EPS (Diluted) for the year ending March 31, 2021 was USD 0.13, a 221.36% change year over year.
Vimta Labs Limited EPS (Diluted) for the year ending March 31, 2020 was USD 0.04, a -75.03% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NSE: VIMTALABS.NS

Vimta Labs Limited

CEO	Dr. Sivalinga Prasad Vasireddi
IPO Date	Dec. 15, 2005
Location	India
Headquarters	Plot Nos. 141/2 & 142, IDA, Phase II
Employees	1,428
Sector	Health Care
Industries Biotechnology Clinical Trials Pharmaceuticals Research & Consulting

Description

Vimta Labs Limited provides contract research and testing services in India and internationally. It offers laboratory, food and water testing and analysis, preclinical and clinical research, biological molecule structural and functional analysis, environmental assessment, and clinical reference laboratory services. The company serves pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and various other industries. Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.

Key trends

Past 5 years